Interaction Guide · Research summary

Can I take Angelica Sinensis with Flurbiprofen?

Review Angelica Sinensis with Flurbiprofen: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

The added bleeding risk from Angelica sinensis with flurbiprofen is uncertain. Review the exact product, dose and your bleeding history with your prescriber.

What this answer covers

Oral Angelica sinensis with oral flurbiprofen tablets. Exact formulation, dose and duration matter; other NSAIDs and other supplement preparations are not interchangeable.

Supplement or preparation
Angelica sinensis
Medication ingredient
flurbiprofen

What the evidence shows

A small study tested Angelica sinensis alone and with aspirin over short treatment periods. Overall platelet and coagulation results did not show a clinically relevant added effect, and significant bleeding manifestations were not reported. The study does not establish safety with this different NSAID.

Consider this medicine’s own effects

Flurbiprofen tablets carry warnings about serious GI bleeding and ulcers, and the label calls for attention to other medicines affecting bleeding. This is a real drug-specific precaution, but it does not establish that every botanical adds to the risk. Evidence involving aspirin or a different route should not be treated as a trial of oral flurbiprofen.

Review the exact product

Check the botanical name, plant part, extract and other ingredients. The inspected abstract does not fully characterize every preparation. Results from a short study of one product cannot establish the effect of another dose or a multi-herb formula.

Know when to get help

oral flurbiprofen tablets can cause serious GI bleeding even without a supplement. Seek urgent care for vomiting blood or black, tarry stools, and report persistent stomach pain or unusual bleeding. Tell your prescriber about other pain medicines, aspirin and anticoagulants. A few hours of separation has not been shown to prevent an added bleeding effect.

Evidence and practical considerations

Side effects & toxicity

An increased bleeding or GI-injury rate specifically from Angelica sinensis with flurbiprofen has not been established.

Exact scope
Oral Angelica sinensis with oral flurbiprofen tablets. Exact formulation, dose and duration matter; other NSAIDs and other supplement preparations are not interchangeable. with Exact flurbiprofen RxCUI 4502 IN, confirmed by RxNorm. Oral racemic tablets; ophthalmic flurbiprofen sodium, lozenges and other routes are not covered.
Medication form and route
Oral

What remains uncertain

  • Available supplement-only and other-drug studies do not establish exact-pair clinical harm or exclude rare events. No validated preventive spacing interval.

Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: Current prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Prescription oral oral flurbiprofen tablets users; short human pharmacology studies where described.

Warns of serious GI bleeding, renal toxicity and hyperkalemia. Bleeding risk assessment includes other medicines affecting hemostasis. Food or antacids may alter absorption rate but not extent.

How this applies: Exact current product label. Exact flurbiprofen RxCUI 4502 IN, confirmed by RxNorm. Oral racemic tablets; ophthalmic flurbiprofen sodium, lozenges and other routes are not covered.

No exact botanical co-use risk estimate. Class safety text is not a measured incidence for each supplement; other routes and sodium ophthalmic products differ.

Source 2: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Approximately 25 healthy volunteers assigned per herb.

No clinically relevant overall platelet/coagulation change or added aspirin inhibition. No significant bleeding manifestations reported.

How this applies: Indirect for oral flurbiprofen tablets co-use; exact preparation and endpoint retained.

Abstract-only; small short study, preparation detail incomplete. Occasional individual platelet responses do not establish clinical bleeding; rare harm or different products not excluded.

Source 3: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

flurbiprofen is IN.

How this applies: Exact identity.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Sources checked and article drafted.
Research summary published

Article revision: 5aba694ff0502efa

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.